JP2019523653A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019523653A5 JP2019523653A5 JP2019514173A JP2019514173A JP2019523653A5 JP 2019523653 A5 JP2019523653 A5 JP 2019523653A5 JP 2019514173 A JP2019514173 A JP 2019514173A JP 2019514173 A JP2019514173 A JP 2019514173A JP 2019523653 A5 JP2019523653 A5 JP 2019523653A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- heavy chain
- item
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2016/083653 WO2017201731A1 (en) | 2016-05-27 | 2016-05-27 | Antibodies, composition and kits comprising same, and methods of use thereof |
| CNPCT/CN2016/083653 | 2016-05-27 | ||
| PCT/CN2017/086280 WO2017202387A1 (en) | 2016-05-27 | 2017-05-27 | Antibodies, composition and kits comprising same, and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019523653A JP2019523653A (ja) | 2019-08-29 |
| JP2019523653A5 true JP2019523653A5 (enExample) | 2020-07-09 |
| JP7210026B2 JP7210026B2 (ja) | 2023-01-23 |
Family
ID=60410923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019514173A Active JP7210026B2 (ja) | 2016-05-27 | 2017-05-27 | 抗体、抗体を含む組成物およびキット、ならびにそれらの使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11192946B2 (enExample) |
| EP (1) | EP3464346A4 (enExample) |
| JP (1) | JP7210026B2 (enExample) |
| KR (1) | KR102540512B1 (enExample) |
| CN (1) | CN109563155B (enExample) |
| AU (1) | AU2017269526B2 (enExample) |
| CA (1) | CA3025217A1 (enExample) |
| WO (2) | WO2017201731A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017201731A1 (en) | 2016-05-27 | 2017-11-30 | Beijing Vdjbio Co., Ltd. | Antibodies, composition and kits comprising same, and methods of use thereof |
| KR20200093628A (ko) * | 2017-11-30 | 2020-08-05 | 바이오-테라 솔루션즈 리미티드 | Il-6 관련 질병을 치료하는 인간화항체의 액체 제제 |
| CN112004577B (zh) | 2018-03-14 | 2024-11-22 | 湖南思为康医药有限公司 | 用于降低毒性的免疫细胞修饰以及其在过继细胞疗法中的用途 |
| WO2019241216A1 (en) * | 2018-06-14 | 2019-12-19 | Bioatla, Llc | Multi-specific antibody constructs |
| AU2020205951A1 (en) * | 2019-01-07 | 2021-07-22 | Hunan Siweikang Therapeutics Co. Ltd | Modified immune cells co-expressing chimeric antigen receptor and il-6 antagonist for reducing toxicity and uses thereof in adoptive cell therapy |
| US12465640B2 (en) | 2019-02-25 | 2025-11-11 | The University Of Chicago | Methods and compositions for treating inflammatory and autoimmune conditions with ECM-affinity peptides linked to anti-inflammatory agents |
| CN113316587B (zh) * | 2019-05-20 | 2024-03-26 | 南通壹宸生物医药科技有限公司 | 一种双特异性分子及其制备与用途 |
| WO2021164107A1 (zh) * | 2020-02-19 | 2021-08-26 | 中国科学技术大学 | Il-6受体抗体的新用途 |
| CN116261448A (zh) * | 2020-08-19 | 2023-06-13 | 百奥泰生物制药股份有限公司 | 用于治疗il-6相关疾病的包含高浓度人源化抗体的液体制剂 |
| CN118591566A (zh) * | 2022-11-07 | 2024-09-03 | 北京伟德杰生物科技有限公司 | 双功能融合蛋白及其应用 |
| WO2024098940A1 (zh) * | 2022-11-07 | 2024-05-16 | 北京伟德杰生物科技有限公司 | 双特异性抗体及其应用 |
| CN120818056A (zh) * | 2024-04-15 | 2025-10-21 | 北京伟德杰生物科技有限公司 | 抗白介素6受体的抗体及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1728801A4 (en) | 2004-03-24 | 2009-10-21 | Chugai Pharmaceutical Co Ltd | SUBTYP OF A HUMANIZED ANTIBODY AGAINST THE INTERLEUKIN-6 RECEPTOR |
| CA2647846C (en) * | 2006-03-31 | 2016-06-21 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
| PL2374818T3 (pl) * | 2006-06-02 | 2013-05-31 | Regeneron Pharma | Przeciwciała o wysokim powinowactwie przeciw ludzkiemu receptorowi IL 6 |
| CN106519025B (zh) * | 2007-09-26 | 2021-04-23 | 中外制药株式会社 | 利用cdr的氨基酸取代来改变抗体等电点的方法 |
| US20110245473A1 (en) | 2007-09-26 | 2011-10-06 | Chugai Seiyaku Kabushiki Kaisha | Anti-IL-6 Receptor Antibody |
| TWI440469B (zh) * | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| RU2013144392A (ru) | 2011-03-03 | 2015-04-10 | Апексиджен, Инк. | Антитела к рецептору il-6 и способы применения |
| WO2014052462A2 (en) * | 2012-09-25 | 2014-04-03 | Cytomx Therapeutics, Inc. | Activatable antibodies that bind interleukin-6 receptor and methods of use thereof |
| WO2017201731A1 (en) | 2016-05-27 | 2017-11-30 | Beijing Vdjbio Co., Ltd. | Antibodies, composition and kits comprising same, and methods of use thereof |
-
2016
- 2016-05-27 WO PCT/CN2016/083653 patent/WO2017201731A1/en not_active Ceased
-
2017
- 2017-05-27 WO PCT/CN2017/086280 patent/WO2017202387A1/en not_active Ceased
- 2017-05-27 CN CN201780046893.5A patent/CN109563155B/zh active Active
- 2017-05-27 JP JP2019514173A patent/JP7210026B2/ja active Active
- 2017-05-27 CA CA3025217A patent/CA3025217A1/en active Pending
- 2017-05-27 AU AU2017269526A patent/AU2017269526B2/en active Active
- 2017-05-27 EP EP17802233.1A patent/EP3464346A4/en active Pending
- 2017-05-27 KR KR1020187037865A patent/KR102540512B1/ko active Active
-
2018
- 2018-11-26 US US16/200,512 patent/US11192946B2/en active Active
-
2021
- 2021-11-04 US US17/519,069 patent/US12006362B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019523653A5 (enExample) | ||
| CN109134658B (zh) | 控制了重链与轻链的缔合的抗原结合分子 | |
| RU2550272C2 (ru) | Новые il-17-связывающие соединения и их медицинское применение | |
| RU2464276C2 (ru) | Улучшенные нанотела против фактора некроза опухоли-альфа | |
| AU2015207915C1 (en) | Isolation and purification of antibodies using Protein A affinity chromatography | |
| WO2022031871A4 (en) | Compositions and methods related to il27 receptor binding | |
| JP2021063129A5 (enExample) | ||
| JP2017018106A5 (enExample) | ||
| JP2015528003A5 (enExample) | ||
| JP2012516158A5 (enExample) | ||
| SI2481753T1 (en) | Anti-IL-17 antibodies | |
| JP2011526792A5 (enExample) | ||
| CN102770537A (zh) | 用于纯化多肽多聚体的多肽的修饰方法 | |
| CN105646643A (zh) | 单域抗原结合性分子的纯化方法 | |
| JP2010528589A5 (enExample) | ||
| JP7384498B2 (ja) | 抗ヒトインターロイキン２３モノクローナル抗体及びその使用 | |
| AU2017361846A1 (en) | T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta | |
| CA2904448A1 (en) | Dual specific binding proteins directed against il-1.beta. and/or il-17 | |
| TW201620935A (zh) | 基於vl和vнн可變區衍生物的高親和力抗聚集抗體 | |
| CN117500824A (zh) | 包含IL-10或TGF-β激动剂多肽的嵌合分子 | |
| JP7680078B2 (ja) | 抗ヒトインターフェロンα受容体１モノクローナル抗体及びその使用 | |
| CN110582512B (zh) | 针对il-17a和il-17f二者的单克隆抗体及其用途 | |
| CN106536567A (zh) | 新型多肽 | |
| TW202204423A (zh) | 用於產生和純化多價免疫球蛋白單可變域的方法 | |
| JPWO2022129572A5 (enExample) |